Giorgio Ottaviani Ph.D.

Giorgio Ottaviani PhD, DABT, currently serves as an Operating Partner at Versant Ventures and the Founding Head of Preclinical Development at SixPeaks Bio. With a robust background in preclinical development, Giorgio holds the position of Senior Vice President of Preclinical Development at Ridgeline Discovery and has previously contributed to multiple companies in similar roles, including Granite Bio and Black Diamond Therapeutics. Educational credentials include a PhD in Pharmaceutical Chemistry from the University of Geneva and a Diplomate certification from the American Board of Toxicology. Giorgio's expertise spans from early discovery to development across various therapeutic platforms and companies.